摘要
目的探讨颅内动脉瘤患者治疗中实施临床路径的效果。方法本次研究对象均为2014年6月—2016年6月来我院就诊的颅内动脉瘤患者,共107例,采用数字随机法分为对照组和研究组,对照组患者53例,采用常规模式,研究组患者54例,采用临床路径,比较两组患者的临床效果。结果研究组的卧床时间和住院时间分别为(5.26±1.03)天和(11.34±2.06)天,对照组时间更短,组间比较差异具有统计学意义(P<0.05);研究组患者发生便秘、感染、压疮和呕吐并发症发生率为33.3%,对照组并发症发生率为64.2%,研究组低于对照组,组间比较差异具有统计学意义(P<0.05)。结论颅内动脉瘤患者治疗中实施临床路径能促进患者快速治愈,同时减少各种并发症的发生。
Objective To discussion the effect which clinical pathway in the treatment of patients with intracranial aneurysms. Methods The subjects of this study were 107 patients with intracranial aneurysms from June 2014 to June 2016, were divided into control group and study group, 53 cases in control group, 54 patients in study group, clinical pathway and clinical effect of two groups were compared. Results The bedridden and length of stay in the study group were （5.26±1.03） days and （11.34±2.06） days, these two indicators were shorter than the control group, the difference between the two groups was statistically significant （P 〈 0.05）; Patients in the study group developed constipation, infection, pressure sores and vomiting complications incidence was 33.3%, The incidence of complications in the control group was 64.2%, the study group was lower than the control group, the difference between the two groups was statistically significant （P 〈 0.05）. Conclusion Clinical Pathway in the Treatment of patients with intracranial aneurysms can promote rapid healing of patients, and the same time reducing the incidence of complications.
出处
《中国卫生标准管理》
2017年第6期164-166,共3页
China Health Standard Management
关键词
颅内动脉瘤
临床路径
效果
intracranial aneurysm
clinical pathway
effect
